Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Cash flows from operating activities:
Net loss	$ (6,438,258)	$ (13,982,504)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation and amortization	1,620	5,413
Stock-based compensation	1,475,141	1,129,446
Stock issued for services	1,610,000	193,250
Amortization of beneficial conversion feature, debt discount and closing costs	555,884	593,787
In-process R& D	0	8,260,000
Financing costs paid with stock	0	169,000
Decrease in asset purchase liability	(1,936)	1,125,026
Gain on forgiveness of long-term debt	0	(50,000)
Changes in operating assets and liabilities:
Increase in prepaid expenses and other current assets	(255,255)	(38,333)
Increase (decrease) in accounts payable	(166,826)	69,457
Increase in accrued wages	563,733	35,170
Increase in accrued interest	101,086	29,056
Net cash used in operating activities	(2,554,811)	(2,461,232)
Cash flows from investing activities:
Purchase of patents	(45,220)	0
Net cash used in investing activities	(45,220)	0
Cash flows from financing activities:
Proceeds from notes payable	375,000	1,565,000
Principal payments made on notes payable	(37,269)	(305,470)
Financing closing costs paid with cash	0	(169,000)
Proceeds from equity financing	1,972,016	2,685,975
Net cash provided by financing activities	2,309,747	3,776,505
Increase (decrease) in cash	(290,284)	1,315,273
Cash:
Beginning of period	556,584	62,952
End of period	266,300	1,378,225
Supplemental disclosure of non-cash information:
Cash paid for interest	954	30,310
Common stock issued for debt financing commitment shares	68,718	197,400
Common stock issued for conversion of notes payable and related accrued interest	0	442,200
Warrants issued in connection with financings	0	634,056
Original issue discount on debt	0	169,200
Stock issued in exchange for closing costs	0	124,965
Beneficial conversion feature recognized	$ 0	$ 19,780